Home/Senseera/Dr. Ronen Sadeh
DR

Dr. Ronen Sadeh

CEO

Senseera

Senseera Pipeline

DrugIndicationPhase
Liver Transplant Rejection AssayAcute cellular rejectionClinical POC
MASH Biomarker PanelNon‑alcoholic steatohepatitisClinical POC
HCC Diagnostic TestHepatocellular carcinomaClinical POC